Emollients for prevention of atopic dermatitis: 5-year findings from the BEEP randomized trial

Bradshaw, Lucy E., Wyatt, Laura A., Brown, Sara J., Haines, Rachel H., Montgomery, Alan A., Perkin, Michael R., Lawton, Sandra, Sach, Tracey H. ORCID: https://orcid.org/0000-0002-8098-9220, Chalmers, Joanne R., Ridd, Matthew J., Flohr, Carsten, Brooks, Joanne, Swinden, Richard, Mitchell, Eleanor J., Tarr, Stella, Jay, Nicola, Thomas, Kim s., Allen, Hilary, Cork, Michael J., Kelleher, Maeve M., Simpson, Eric l., Lartey, Stella T. ORCID: https://orcid.org/0000-0001-9519-7886, Davies‐jones, Susan, Boyle, Robert J. and Williams, Hywel C. (2022) Emollients for prevention of atopic dermatitis: 5-year findings from the BEEP randomized trial. Allergy. ISSN 0105-4538

[thumbnail of Allergy - 2022 - Bradshaw - Emollients for prevention of atopic dermatitis  5�year findings from the BEEP randomized trial]
Preview
PDF (Allergy - 2022 - Bradshaw - Emollients for prevention of atopic dermatitis 5�year findings from the BEEP randomized trial) - Published Version
Available under License Creative Commons Attribution.

Download (2MB) | Preview

Abstract

Background: The effectiveness of emollients for preventing atopic dermatitis/eczema is controversial. The Barrier Enhancement for Eczema Prevention trial evaluated the effects of daily emollients during the first year of life on atopic dermatitis and atopic conditions to age 5 years. Methods: 1394 term infants with a family history of atopic disease were randomized (1:1) to daily emollient plus standard skin-care advice (693 emollient group) or standard skin-care advice alone (701 controls). Long-term follow-up at ages 3, 4 and 5 years was via parental questionnaires. Main outcomes were parental report of a clinical diagnosis of atopic dermatitis and food allergy. Results: Parents reported more frequent moisturizer application in the emollient group through to 5 years. A clinical diagnosis of atopic dermatitis between 12 and 60 months was reported for 188/608 (31%) in the emollient group and 178/631 (28%) in the control group (adjusted relative risk 1.10, 95% confidence interval 0.93 to 1.30). Although more parents in the emollient group reported food reactions in the previous year at 3 and 4 years, cumulative incidence of doctor-diagnosed food allergy by 5 years was similar between groups (92/609 [15%] emollients and 87/632 [14%] controls, adjusted relative risk 1.11, 95% confidence interval 0.84 to 1.45). Findings were similar for cumulative incidence of asthma and hay fever. Conclusions: Daily emollient application during the first year of life does not prevent atopic dermatitis, food allergy, asthma or hay fever.

Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 15 Dec 2022 04:00
Last Modified: 15 Dec 2022 04:00
URI: https://ueaeprints.uea.ac.uk/id/eprint/90116
DOI: 10.1111/all.15555

Actions (login required)

View Item View Item